Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -36.48%-24.1M | ---- | 65.48%-17.66M | ---- | -191.52%-51.17M | ---- | -14.09%-17.55M | ---- | 46.78%-15.38M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -40.00%-7K | ---- | 66.67%-5K | ---- | 40.00%-15K | ---- | -13.64%-25K | ---- | 35.29%-22K |
| Impairment and provisions: | ---- | --5.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | --5.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -8.20%6.71M | ---- | -54.79%7.3M | ---- | 128.98%16.16M | ---- | 139.51%7.06M | ---- | 147,400.00%2.95M |
| -Fair value of investment properties (increase) | ---- | -8.20%6.71M | ---- | -54.79%7.3M | ---- | 128.98%16.16M | ---- | 139.51%7.06M | ---- | --2.95M |
| Depreciation and amortization: | ---- | -2.64%3.28M | ---- | -3.99%3.37M | ---- | -19.62%3.51M | ---- | -30.53%4.36M | ---- | -41.80%6.28M |
| Financial expense | ---- | -8.50%2.93M | ---- | -19.04%3.2M | ---- | 1.91%3.95M | ---- | 13.22%3.88M | ---- | -37.37%3.43M |
| Operating profit before the change of operating capital | ---- | -56.09%-5.92M | ---- | 86.24%-3.79M | ---- | -1,110.94%-27.56M | ---- | 17.27%-2.28M | ---- | 26.44%-2.75M |
| Change of operating capital | ||||||||||
| Developing property (increase)decrease | ---- | ---- | ---- | ---- | ---- | 83.56%-1.88M | ---- | 67.58%-11.45M | ---- | -9,294.53%-35.31M |
| Accounts receivable (increase)decrease | ---- | 90.55%-646K | ---- | -118.10%-6.84M | ---- | 255.13%37.76M | ---- | -285.15%-24.34M | ---- | 124.56%13.15M |
| Accounts payable increase (decrease) | ---- | -116.86%-1.29M | ---- | 91.23%-593K | ---- | -557.24%-6.76M | ---- | 139.32%1.48M | ---- | 68.76%-3.76M |
| Special items for working capital changes | ---- | -48.29%12.37M | ---- | 142.46%23.92M | ---- | -54.25%9.87M | ---- | -17.20%21.56M | ---- | -37.54%26.05M |
| Cash from business operations | ---- | -64.42%4.52M | ---- | 11.13%12.7M | ---- | 176.05%11.43M | ---- | -472.60%-15.03M | ---- | 84.48%-2.62M |
| Other taxs | ---- | 27.82%-428K | ---- | -4.22%-593K | ---- | 51.24%-569K | ---- | -16.12%-1.17M | ---- | 41.02%-1.01M |
| Special items of business | -3.51%2.17M | ---- | -81.66%2.25M | ---- | 134.62%12.27M | ---- | 3,809.93%5.23M | ---- | 99.04%-141K | ---- |
| Net cash from operations | -3.51%2.17M | -66.22%4.09M | -81.66%2.25M | 11.49%12.11M | 134.62%12.27M | 167.06%10.86M | 3,809.93%5.23M | -346.18%-16.19M | 99.04%-141K | 80.50%-3.63M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -33.33%2K | 40.00%7K | 0.00%3K | -66.67%5K | -72.73%3K | -40.00%15K | -8.33%11K | 13.64%25K | 0.00%12K | -35.29%22K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -145.99%-1.51M | 108.44%1.5M |
| Purchase of fixed assets | ---- | 84.75%-70K | 84.33%-71K | -897.83%-459K | -1,462.07%-453K | -91.67%-46K | ---29K | -71.43%-24K | ---- | 99.70%-14K |
| Net cash from investment operations | 102.94%2K | 86.12%-63K | 84.89%-68K | -1,364.52%-454K | -2,400.00%-450K | -3,200.00%-31K | 98.80%-18K | -99.93%1K | -145.65%-1.5M | 103.19%1.51M |
| Net cash before financing | -0.41%2.17M | -65.44%4.03M | -81.54%2.18M | 7.62%11.65M | 126.80%11.82M | 166.87%10.83M | 417.67%5.21M | -664.09%-16.19M | 85.66%-1.64M | 96.78%-2.12M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 70.08%1.26M | ---- | 110.05%742K | ---- | ---7.39M | ---- | ---- | --18.25M | ---- | ---- |
| Refund | --21K | 88.86%-956K | ---- | 47.44%-8.58M | 99.17%-82K | -909.83%-16.33M | ---9.94M | ---1.62M | ---- | ---- |
| Interest paid - financing | -50.91%-249K | 34.77%-469K | -2,650.00%-165K | 13.37%-719K | 99.55%-6K | -116.71%-830K | -581.12%-1.34M | 39.01%-383K | 88.33%-196K | 86.52%-628K |
| Issuance expenses and redemption of securities expenses | -189.00%-578K | 84.87%-200K | 86.82%-200K | ---1.32M | ---1.52M | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 32.23%279K | 82.22%-1.96M | 102.30%211K | 36.90%-11.04M | 19.60%-9.18M | -216.95%-17.49M | -1,055.97%-11.42M | 983.28%14.95M | 57.27%-988K | -172.51%-1.69M |
| Effect of rate | -20.46%1.22M | 83.88%-39K | 165.47%1.53M | 86.67%-242K | 40.76%-2.34M | -199.56%-1.82M | -223.71%-3.95M | -12.82%1.82M | -69.01%3.19M | 10.81%2.09M |
| Net Cash | 2.46%2.45M | 234.68%2.07M | -9.35%2.39M | 109.26%617K | 142.54%2.64M | -438.56%-6.66M | -136.14%-6.21M | 67.55%-1.24M | 80.88%-2.63M | 94.00%-3.81M |
| Begining period cash | 44.32%6.6M | 8.94%4.57M | 8.94%4.57M | -66.89%4.2M | -66.89%4.2M | 4.85%12.67M | 4.85%12.67M | -12.46%12.09M | -12.46%12.09M | -81.71%13.81M |
| Cash at the end | 20.86%10.27M | 44.32%6.6M | 88.78%8.5M | 8.94%4.57M | 78.57%4.5M | -66.89%4.2M | -80.07%2.52M | 4.85%12.67M | 22.23%12.65M | -12.46%12.09M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.23%12.65M | -12.46%12.09M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.23%12.65M | -12.46%12.09M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.